Somehow, businesses now care more about the tools they use than what they use them for. In a sense, using AI as a tool has become the end itself rather than a means to an end. Would you decide to use a hammer for your house-improvement project no matter what you plan to do?

Is “over-engineering” sexy or not? With Tepsivo landing in Deloitte Technology Fast 50 this year, we argue that it is actually a very rational strategy to fight industry dinosaurs. And more importantly – a replicable one. So the question is: How about building your own cathedral?

Before we start considering what the future of pharmacovigilance will look like, should we not address first what it already could be today? We believe the current global spend on pharmacovigilance is actually much higher than it should be. Let’s dive into the topic more in this article.

Addendum II on masking of personal data in individual case safety reports (ICSR) submitted to EudraVigilance (EV) became effective on 25th of July 2025. What does that mean for MAHs in practice? In this blog post, we summarize the impact on several categories of ICSR fields and closely related areas.